CUFinder

anju peters

About anju peters

anju peters, With an exceptional h-index of 64 and a recent h-index of 46 (since 2020), a distinguished researcher at North Western University, specializes in the field of allergy-immunology, rhinosinusitis, asthma.

His recent articles reflect a diverse array of research interests and contributions to the field:

Clinical Responses to Tezepelumab in Patients With Severe, Uncontrolled Asthma, and a History of Nasal Polyps From the NAVIGATOR Study

The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps

Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study

Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma

Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and …

The effect of sinus surgery on the development of asthma and bronchiectasis in patients with chronic rhinosinusitis

Coexisting Allergic Rhinitis In Patients With Moderate-To-Severe Asthma Initiating Dupilumab In Real-World Clinical Practice: The RAPID Registry Study

Prevalence of NSAID-ERD Among Patients with Chronic Rhinosinusitis with Nasal Polyps in the Global AROMA registry

anju peters Information

University

Position

___

Citations(all)

14012

Citations(since 2020)

8611

Cited By

8703

hIndex(all)

64

hIndex(since 2020)

46

i10Index(all)

143

i10Index(since 2020)

123

Email

University Profile Page

Google Scholar

anju peters Skills & Research Interests

allergy-immunology

rhinosinusitis

asthma

Top articles of anju peters

Clinical Responses to Tezepelumab in Patients With Severe, Uncontrolled Asthma, and a History of Nasal Polyps From the NAVIGATOR Study

2024/5

The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps

2024/4/16

Claus Bachert
Claus Bachert

H-Index: 85

Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation Study

The Journal of Allergy and Clinical Immunology: In Practice

2023/12/30

Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma

Annals of Allergy, Asthma & Immunology

2023/11/25

Xavier Soler
Xavier Soler

H-Index: 22

Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and …

International forum of allergy & rhinology

2024/3

Claus Bachert
Claus Bachert

H-Index: 85

The effect of sinus surgery on the development of asthma and bronchiectasis in patients with chronic rhinosinusitis

Journal of Allergy and Clinical Immunology

2024/2/1

David Conley
David Conley

H-Index: 28

Atsushi Kato
Atsushi Kato

H-Index: 38

Robert Schleimer
Robert Schleimer

H-Index: 55

Brian Schwartz
Brian Schwartz

H-Index: 8

Kevin Welch
Kevin Welch

H-Index: 1

Stephanie Smith
Stephanie Smith

H-Index: 2

Anju Peters
Anju Peters

H-Index: 43

Coexisting Allergic Rhinitis In Patients With Moderate-To-Severe Asthma Initiating Dupilumab In Real-World Clinical Practice: The RAPID Registry Study

Journal of Allergy and Clinical Immunology

2024/2/1

Anju Peters
Anju Peters

H-Index: 43

Xavier Soler
Xavier Soler

H-Index: 22

Prevalence of NSAID-ERD Among Patients with Chronic Rhinosinusitis with Nasal Polyps in the Global AROMA registry

Journal of Allergy and Clinical Immunology

2024/2/1

Andrew White
Andrew White

H-Index: 1

Anju Peters
Anju Peters

H-Index: 43

Micah Johnson
Micah Johnson

H-Index: 4

The impact of functional endoscopic sinonasal surgery on oral corticosteroid use and costs over 3 years in patients with chronic rhinosinusitis with nasal polyps in US real …

Journal of Allergy and Clinical Immunology

2024/2/1

Stella Lee
Stella Lee

H-Index: 46

Anju Peters
Anju Peters

H-Index: 43

Baseline Use of Oral Corticosteroids Among Patients With Chronic Rhinosinusitis With Nasal Polyps Enrolled In The Global AROMA Registry

Journal of Allergy and Clinical Immunology

2024/2/1

Anju Peters
Anju Peters

H-Index: 43

Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA registry

Journal of Allergy and Clinical Immunology

2024/2/1

Anju Peters
Anju Peters

H-Index: 43

Micah Johnson
Micah Johnson

H-Index: 4

Efficacy of Biologics in Patients With Moderate-to-Severe, Uncontrolled Asthma and Nasal Polyps

Journal of Allergy and Clinical Immunology

2024/2/1

Anju Peters
Anju Peters

H-Index: 43

Post Surgical Endotyping Better Predicts Long-Term Outcomes in CRS Patients

Journal of Allergy and Clinical Immunology

2024/2/1

Aditi Agarwal
Aditi Agarwal

H-Index: 6

Siyuan Dong
Siyuan Dong

H-Index: 20

David Conley
David Conley

H-Index: 28

Kevin Welch
Kevin Welch

H-Index: 1

Anju Peters
Anju Peters

H-Index: 43

Atsushi Kato
Atsushi Kato

H-Index: 38

Robert Schleimer
Robert Schleimer

H-Index: 55

Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2)

The Journal of Allergy and Clinical Immunology: In Practice

2024/1/18

Mahboobeh Mahdavinia
Mahboobeh Mahdavinia

H-Index: 20

EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP.

2024/1/13

Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up

International Forum of Allergy & Rhinology

2024/1

Evaluating treatment responses of dupilumab versus omalizumab in severe chronic rhinosinusitis with nasal polyps and comorbid asthma patients: The Everest trial

Journal of Allergy and Clinical Immunology

2022/2/1

Asif Khan
Asif Khan

H-Index: 25

Anju Peters
Anju Peters

H-Index: 43

Claus Bachert
Claus Bachert

H-Index: 85

Mei Zhang
Mei Zhang

H-Index: 15

Rhinitis and rhinosinusitis: Literature Review 2022

2023/2/1

1237. Inpatients with a beta-lactam antibiotic allergy label (BAAL) and unrevealed tolerance: A prevalence study aimed to prioritize non-invasive delabeling for antimicrobial …

Open Forum Infectious Diseases

2023/12

Hoang Tran
Hoang Tran

H-Index: 0

The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis

Journal of Allergy and Clinical Immunology

2022/11/9

Julie Wang
Julie Wang

H-Index: 11

See List of Professors in anju peters University(North Western University)